| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |